| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||
Net income (loss) | ||||||||||
-3,546 | -7,038 | -8,049 | -1,003 | 671 | 2,362 | -2,151 | 5,806 | 5,626 | 2,427 | 3,058 |
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities: | ||||||||||
Depreciation and amortization expense | ||||||||||
4,404 | 2,982 | 2,647 | 2,396 | 2,246 | 1,989 | 1,301 | 901 | 1,040 | 978 | 816 |
Deferred tax expense | ||||||||||
65 | 81 | 4,206 | 619 | 490 | -309 | -1,579 | -829 | 1,665 | -332 | -525 |
Share-based compensation | ||||||||||
1,485 | 1,364 | 1,115 | 852 | 622 | 761 | 674 | 636 | 779 | 768 | - |
Share-based compensation (foundation contribution) | ||||||||||
0 | 0 | 372 | 0 | 0 | - | - | - | - | - | - |
Stock-based compensation - nonemployees | ||||||||||
- | - | - | - | - | - | - | - | - | - | 1,056 |
Stock-based compensation - employees | ||||||||||
- | - | - | - | - | - | - | - | - | - | 606 |
Decrease in non-cash contingent consideration | ||||||||||
0 | 81 | 91 | -1,026 | 90 | 1,653 | 48 | 3,760 | 2,355 | 3,874 | 3,968 |
Decrease in non-cash contingent consideration | ||||||||||
804 | 0 | 0 | - | - | - | - | - | - | - | - |
Noncash interest expense | ||||||||||
47 | 99 | 77 | 84 | 46 | 38 | 24 | 24 | 137 | 352 | 128 |
Noncash investment gains | ||||||||||
26 | 168 | 52 | 74 | 77 | 52 | -178 | 45 | 0 | 0 | - |
Net changes in assets and liabilities affecting operating activities: | ||||||||||
Accounts receivable | ||||||||||
1,937 | -550 | 1,064 | 1,253 | 572 | 974 | -1,486 | -1,065 | 1,937 | -1,031 | 3,047 |
Inventories | ||||||||||
-2,860 | -460 | 1,366 | 1,101 | -1,330 | -1,532 | -495 | 443 | -1,909 | 2,860 | 3,060 |
Other current assets and other assets | ||||||||||
587 | -712 | 1,074 | 1,556 | 263 | 1,011 | -117 | 648 | 399 | -1,342 | - |
Prepaid, other current assets and other assets | ||||||||||
- | - | - | - | - | - | - | - | - | - | 721 |
Accounts payable and other current liabilities | ||||||||||
1,824 | 4,308 | 2,307 | 191 | 1,475 | 3,846 | 58 | 4,373 | 2,296 | 201 | 6,572 |
Other long-term liabilities | ||||||||||
-729 | -159 | 413 | 386 | -2 | 162 | 187 | 56 | -40 | 313 | - |
Other long-term liabilities | ||||||||||
- | - | - | - | - | - | - | - | - | - | -510 |
Net cash provided by (used in) operating activities | ||||||||||
3,056 | 3,112 | -557 | 569 | 5,876 | 6,693 | 746 | 7,135 | 8,722 | 346 | 404 |
Cash flows from investing activities: | ||||||||||
Additions to property and equipment | ||||||||||
246 | 455 | 275 | 130 | 142 | 163 | 97 | 464 | 257 | 577 | 601 |
Cash paid for acquisition | ||||||||||
5,000 | 20,000 | 0 | 0 | - | 2,000 | 0 | 0 | - | - | - |
Proceeds from sale of marketable securities | ||||||||||
20,062 | 16,122 | 13,381 | 4,489 | 7,883 | 3,437 | 6,859 | 5,220 | 0 | 0 | - |
Purchases of marketable securities | ||||||||||
11,745 | 19,572 | 2,379 | 5,473 | 7,528 | 4,207 | 4,371 | 21,860 | 0 | 0 | - |
Additions to intangible assets | ||||||||||
772 | 3,819 | 1,213 | 2,000 | 2,556 | 3,101 | 7,462 | 2,071 | 180 | 191 | 110 |
Net cash used in investing activities | ||||||||||
2,297 | -27,724 | 9,512 | -3,115 | -2,344 | -6,034 | -5,071 | -19,177 | -437 | -768 | -712 |
Cash flows from financing activities: | ||||||||||
Borrowings on line of credit | ||||||||||
76,000 | 56,000 | 24,500 | 2,400 | 1,700 | 0 | -4,359 | -500 | 3,034 | 0 | - |
Proceeds from borrowings on long-term debt | ||||||||||
- | - | - | - | - | - | - | - | - | - | 18,000 |
Repayments on line of credit | ||||||||||
77,500 | 45,800 | 18,800 | 0 | 0 | - | - | - | 5,333 | 12,666 | 5,000 |
Proceeds from initial public offering of common stock | ||||||||||
- | - | - | - | - | - | - | - | - | - | 85,000 |
Payments of deferred equity offering costs | ||||||||||
0 | 383 | 27 | 0 | 0 | - | - | - | - | - | 7,479 |
Sales of shares of common stock, net of offering costs | ||||||||||
0 | 200 | 0 | 0 | 21 | 0 | -41 | 618 | 629 | 1,362 | 175 |
Payments of financing costs | ||||||||||
52 | 0 | 0 | - | 1,668 | 0 | 0 | - | 17 | 110 | 189 |
Cash payment of contingent consideration | ||||||||||
1,033 | 0 | 0 | - | - | - | - | - | - | - | - |
Repurchase of common shares | ||||||||||
3,494 | 2,879 | 3,724 | 2,520 | 5,338 | 4,315 | 4,800 | 8,086 | 4,247 | 4,846 | 27,295 |
Sale of subsidiary shares to noncontrolling interest | ||||||||||
1,000 | 0 | 0 | - | - | 1,000 | 0 | 0 | - | - | - |
Excess tax (expense) benefit derived from exercise of stock options | ||||||||||
- | - | - | -1,026 | 90 | 1,653 | 48 | 3,760 | 2,355 | 3,874 | 3,968 |
Net cash used in financing activities | ||||||||||
-5,080 | 7,138 | 1,947 | -1,147 | -5,194 | -1,662 | -9,154 | -4,207 | -3,579 | -12,385 | 67,179 |
Net decrease in cash and cash equivalents | ||||||||||
273 | -17,473 | 10,902 | - | - | - | - | - | - | - | - |
Net decrease in cash and cash equivalents | ||||||||||
- | - | - | -3,692 | -1,662 | -1,003 | -13,479 | -16,249 | 4,705 | -12,807 | 66,872 |
Supplemental non-cash operating, investing and financing activities: | ||||||||||
Net cash paid (refunded) during the year for: | ||||||||||
Interest | ||||||||||
198 | 95 | 14 | - | - | - | - | - | - | - | - |
Interest | ||||||||||
- | - | - | 21 | 27 | 28 | 79 | 47 | 191 | 814 | 677 |
Income taxes | ||||||||||
16 | 15 | 18 | -8 | 52 | 17 | - | - | - | - | - |
Income taxes | ||||||||||
- | - | - | - | - | - | -129 | 112 | 304 | 52 | 196 |
Noncash investing and financing activities: | ||||||||||
Change in unpaid invoices for purchases of intangibles | ||||||||||
-576 | -539 | -513 | -1,179 | 967 | -1,574 | 543 | 888 | 97 | 0 | - |
Deferred offering costs included in accounts payable and other accrued expenses | ||||||||||
0 | 0 | 97 | 0 | 0 | - | - | - | - | - | - |
Non cash increase in liabilities related to acquisition (see Note 3) | ||||||||||
0 | 14,034 | 0 | 0 | - | - | - | - | - | - | - |
Recognition of operating lease assets and liabilities through adoption of ASC 842 | ||||||||||
3,629 | - | - | - | - | - | - | - | - | - | - |
Vesting of shares related to RediTrex approval | ||||||||||
862 | 0 | 0 | - | - | - | - | - | - | - | - |
Repurchase of subsidiary shares from noncontrolling interests | ||||||||||
800 | 0 | 0 | - | - | - | - | - | - | - | - |
Additions to intangible assets from final purchase price allocation | ||||||||||
148 | 0 | 0 | - | - | - | - | - | - | - | - |
Reclass of redeemable common stock to (from) equity | ||||||||||
- | - | - | - | - | - | - | - | - | 1,930 | -1,930 |
Deferred financing costs | ||||||||||
- | - | - | - | - | - | - | - | - | - | 335 |